D
Deutsche Biotech Innovativ AG
F:DBI
Deutsche Biotech Innovativ AG
F:DBI
Price:
5.05
EUR
Market Cap:
€4.8m
Balance Sheet
Balance Sheet Decomposition
Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG
Balance Sheet Decomposition is not available for
Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG
Balance Sheet
Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG
Currency: EUR
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Total Assets |
2
N/A
|
3
+90%
|
2
-22%
|
2
-4%
|
2
+0%
|
2
-11%
|
2
+17%
|
2
-1%
|
2
-5%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
+284%
|
0
-81%
|
0
+9%
|
0
+175%
|
0
+60%
|
1
+169%
|
1
+18%
|
1
+9%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
1
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Equity |
1
N/A
|
2
+73%
|
2
-11%
|
2
-5%
|
2
-8%
|
2
-21%
|
1
-25%
|
1
-20%
|
1
-26%
|
|
| Total Liabilities & Equity |
2
N/A
|
3
+90%
|
2
-22%
|
2
-4%
|
2
+0%
|
2
-11%
|
2
+17%
|
2
-1%
|
2
-5%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Switch to:
Switch to:
See Also
Discover More
